Zybio Europe

Zybio Europe is a division of Zybio Inc., a high-tech company focused on the research, development, manufacturing, and sales of in vitro diagnostic (IVD) reagents and equipment. Founded in 2008 and headquartered in Chongqing, China, Zybio employs over 3,300 people and invests significantly in innovation, dedicating at least 15% of its sales revenue to research and development. The company offers a wide range of diagnostic products and services, including clinical chemistry, immunoassay, molecular diagnosis, point-of-care testing, hematology, microbiology, and pathological diagnostics. Zybio has developed advanced COVID-19 diagnostic products, such as nucleic acid extraction systems and detection kits, many of which are CE certified for the European market. Additionally, Zybio provides the EXS2600 mass spectrometry system for rapid microbial identification, enhancing clinical microbiology diagnostics. With a global reach, Zybio serves customers in nearly 90 countries and collaborates with medical institutions to deliver innovative diagnostic solutions.

• Employees 2